Reperfusion strategy for ST-segment elevation myocardial infarction: trend over a 10-year period

被引:0
作者
Wu, K. L. [1 ]
Tsui, K. L. [1 ]
Lee, K. T. [1 ]
Chau, C. H. [1 ]
Chan, H. L. [1 ]
Cheung, S. H. [1 ]
Cheung, C. Y. [1 ]
Choi, M. C. [1 ]
Chan, K. K. [1 ]
Li, S. K. [1 ]
机构
[1] Pamela Youde Nethersole Eastern Hosp, Dept Med, Chaiwan, Hong Kong, Peoples R China
关键词
Angioplasty; balloon; coronary; Myocardial infarction; Myocardial reperfusion; Thrombolytic therapy; INTRAVENOUS THROMBOLYTIC THERAPY; 2007 FOCUSED UPDATE; CORONARY ANGIOPLASTY; MANAGEMENT; OUTCOMES; GUIDELINES; REGISTRY; FLOW;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To review the 10-year trend of reperfusion strategies in patients with ST-segment elevation myocardial infarction, and the adoption rate of percutaneous coronary interventions as opposed to thrombolytic therapy. Also to explore why some patients did not receive reperfusion therapy, and document changes in reperfusion strategies after the introduction of primary percutaneous coronary intervention programmes. Design Case series. Setting A regional hospital, Hong Kong. Patients All patients with ST-segment elevation myocardial infarction from January 2000 to December 2009. Results There were 1835 patients with ST-segment elevation myocardial infarction in that period, of which 1179 (64.3%) received reperfusion therapy (thrombolytic therapy, 46.0%; primary percutaneous coronary intervention, 17.5%; emergency coronary artery bypass graft, 0.7%). After introduction of the primary percutaneous coronary intervention programme, significantly more ST-segment elevation myocardial infarction cases underwent that particular intervention (1.6% in 2000 increasing to 30.6% in 2009), while the proportion receiving thrombolytic therapy declined (57.4% in 2000 decreasing to 35.0% in 2009). Seven reasons for no reperfusion therapy were identified. The commonest ones were delayed presentation (45.1%), succumbed before reperfusion (16.0%), multiple medical co-morbidities (15.2%), and contra-indication to thrombolytic therapy (14.8%). The proportion without reperfusion therapy due to a contra-indication to thrombolytic therapy declined (22.7% in 2000 decreasing to 4.9% to 2009), whilst an increasing proportion received primary percutaneous coronary interventions. Conclusions Primary percutaneous coronary intervention is increasingly used as the reperfusion therapy in ST-segment elevation myocardial infarction and is replacing thrombolytic therapy, though the latter still remains a mainstay of therapy. A significant proportion of ST-segment elevation myocardial infarction cases received no reperfusion due to various reasons.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 24 条
  • [1] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
    Andersen, HR
    Nielsen, TT
    Rasmussen, K
    Thuesen, L
    Kelbaek, H
    Thayssen, P
    Abildgaard, U
    Pedersen, F
    Madsen, JK
    Grande, P
    Villadsen, AB
    Krusell, LR
    Haghfelt, T
    Lomholt, P
    Husted, SE
    Vigholt, E
    Kjaergard, HK
    Mortensen, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 733 - 742
  • [2] 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction - A report of the American college of cardiology/American heart association task force on practice guidelines
    Antman, Elliott M.
    Hand, Mary
    Armstrong, Paul W.
    Bates, Eric R.
    Green, Lee A.
    Halasyamani, Lakshmi K.
    Hochman, Judith S.
    Krumholz, Harlan M.
    Lamas, Gervasio A.
    Mullany, Charles J.
    Pearle, David L.
    Sloan, Michael A.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2008, 117 (02) : 296 - 329
  • [3] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [4] Spontaneous reperfusion in ST-elevation myocardial infarction: Comparison of angiographic and electrocardiographic assessments
    Bainey, Kevin R.
    Fu, Yuling
    Wagner, Galen S.
    Goodman, Shaun G.
    Ross, Allan
    Granger, Christopher B.
    Van de Werf, Frans
    Armstrong, Paul W.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (02) : 248 - 255
  • [5] Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian Registry
    Balzi, Daniela
    Barchielli, Alessandro
    Santoro, Giovanni Maria
    Carrabba, Nazario
    Buiatti, Eva
    Giglioli, Cristina
    Valente, Serafina
    Baldereschi, Giorgio
    Del Bianco, Laura
    Monami, Matteo
    Gensini, Gian Franco
    Marchionni, Niccolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (02) : 109 - 115
  • [6] Berton G, 2001, Ital Heart J, V2, P766
  • [7] Determinants and prognostic impact of compliance with guidelines in reperfusion therapy for ST-segment elevation myocardial infarction: Results from the ESTIM Midi-Pyrenees Area
    Charpentier, Sandrine
    Sagnes-Raffy, Christine
    Cournot, Maxime
    Cambou, Jean-Pierre
    Ducasse, Jean-Louis
    Lauque, Dorninique
    Puel, Jacques
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2009, 102 (05) : 387 - 396
  • [8] Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: Preliminary results from the TETAMI registry and randomized trial
    Cohen, M
    Gensini, GF
    Maritz, F
    Gurfinkel, EP
    Huber, K
    Timerman, A
    Krzeminska-Pakula, M
    Santopinto, J
    Hecquet, C
    Vittori, L
    [J]. CIRCULATION, 2003, 108 (16) : 14 - 21
  • [9] Cucherat M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001560.pub2
  • [10] Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction:: findings from the Global Registry of Acute Coronary Events (GRACE)
    Eagle, KA
    Goodman, SG
    Avezum, A
    Budaj, A
    Sullivan, CM
    López-Sendón, J
    [J]. LANCET, 2002, 359 (9304) : 373 - 377